The Burning Question: Who Will Foot the Bill for America ’s Increasing Burn-Care Costs?

By CELIA BELT  Each year in the United States, half a million Americans will be treated for burns so severe as to require hospitalization. The “survivors”—including more than three hundred children each day and a drastically increasing number of U.S. military members since the turn of the millennium—can be expected to undergo arduous, agonizing surgeries and painful rehabilitation lasting for years. The emotional and physical trauma of these fellow citizens is not a pretty picture, nor is it an inexpensive one. According to estimates, patients with severe burns with no complications can expect a whopping $1.6 million bill for treatment over the cost of their lifetime. For patients who do go on to develop complications as the result of severe burns, hospital bills can run more than $10 million. Where is that money coming from? Partly, it comes from you and me in the form of increased healthcare premiums. But oftentimes, it comes from directly people like me, the cofounder of the Moonlight Fund, a Texas-based non-profit organization for burn survivors and their families. We’re often tasked with raising funds to help with the costs of expensive procedures in addition to the emotional support and caregiver assistance our organization was founded for. Many times, I’ve reached into my own pocket—not because I’m a saint, but because I’ve been there.  As a childhood burn survivor myself, scalded ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Patients burn victims burns Celia Belt hospital bills non-profits Source Type: blogs

Related Links:

Christian Klemann, Nadezhda Camacho-Ordonez, Linlin Yang, Zoya Eskandarian, Jessica L. Rojas-Restrepo, Natalie Frede, Alla Bulashevska, Maximilian Heeg, Moudjahed Saleh Al-Ddafari, Julian Premm, Maximilian Seidl, Sandra Ammann, Roya Sherkat, Nita Radhakrishnan, Klaus Warnatz, Susanne Unger, Robin Kobbe, Anja H üfner, T. Ronan Leahy, Winnie Ip, Siobhan O. Burns, Manfred Fliegauf, Bodo Grimbacher
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Chem. Commun., 2019, Accepted Manuscript DOI: 10.1039/C9CC01718F, CommunicationEuan B. Mclean, Vincent Gauchot, Sebastian Brunen, David J Burns, Ai-Lan Lee The use of copper catalysis with visible light photoredox catalysis in a cooperative fashion has recently emerged as a versatile means of developing new C-C bond forming reactions. In this... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
Hill-Rom announced March 12, 2019 that it was in the process of acquiring Voalte for $180 million. An additional $15 million earn out was also disclosed. With annual revenue approaching $40M, the enterprise-value to revenue multiple for Voalte is a over 4.5. The acquisition is expected to close during Hill-Rom's third quarter of 2019, which ends June 30th 2019.  Voalte was rumored to be for sale since Q4 of 2018. Voalte Profile Founded by Trey Lauderdale in 2008, Voalte is located in Sarasota, Florida and currently has about 140 employees. Voalte sells perpetual software licenses, services and resells ...
Source: Medical Connectivity Consulting - Category: Information Technology Authors: Tags: Company Profiles Messaging & Orchestration Strategy & Planning Source Type: blogs
Adverse Childhood Experiences (ACEs), including child maltreatment and household dysfunction, define adverse events that occur before 18 years of age. National and state data show that between 12.5 and 14.5% of the adult population report ≥4 ACEs (HIGH-A...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Abstract In the 2015 Ken Burns documentary, Cancer: The Emperor of All Maladies, based on Siddhartha Mukherjee's The Emperor of All Maladies, the 2011 nonfiction award-winning biography about cancer, we are introduced to the first pediatric patient who received an experimental cellular therapy at Children's Hospital of Philadelphia. The outcomes for that patient, initially treated in 2012 and now almost seven years into survivorship, led to the development of clinical trials with commercially developed chimeric antigen receptor (CAR) T-cell products. PMID: 30880818 [PubMed - in process]
Source: Clinical Journal of Oncology Nursing - Category: Nursing Authors: Tags: Clin J Oncol Nurs Source Type: research
Zipline drones populate the Rwandan skyline, portable electrocardiogram machines help doctors diagnose in clinics in rural India, easy testing lets cure children in Botswana. Beyond being brilliant medical innovations, at some point, all these technologies were brought to or should be applied to high-income countries after their success in their original settings in Africa or Asia – as they have been available for a fraction of the cost, they have represented a highly creative solution and/or the regulatory environment has allowed them to thrive. That’s what researchers call reverse innovation, and we tracked d...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Future of Medicine Portable Diagnostics Telemedicine & Smartphones Africa asia development digital health disruption disruptive drones empowerment Healthcare Innovation medical drones reverse innovation technology West Source Type: blogs
Burned out listening to burn-out talks? An intense session at ACC.19 left Melissa Walton-Shirley, MD, hopeful that some of those words would finally turn into on Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news
Scientists have used a new genetic tool in mice to map out the cellular brain circuits used by the hormone leptin to control energy balance (calories consumed versus calories burned) and blood glucose (sugar) levels. 
Source: NIDDK News - Category: Endocrinology Source Type: news
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - Category: Genetics & Stem Cells Authors: Source Type: research
Synfacts 2019; 15: 0461- DOI: 10.1055/s-0037-1612378 © Georg Thieme Verlag Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Full text
Source: Synfacts - Category: Chemistry Authors: Tags: Erratum Source Type: research
More News: Blogging | Burns | Children | Grants | Health | Health Management | Hospitals | Psychology | Rehabilitation | Skin | USA Health